Healx Logo

Healx Blog - Page 2 of 8 - Healx

Healx Blog

Healx joins forces with Boehringer Ingelheim to discover new treatment approaches for rare neurological diseases

Cambridge, UK – 9 December 2019 – Healx the AI-powered biotechnology company focused on developing breakthrough treatments for rare diseases, today announces it has entered into an agreement with Boehringer Ingelheim to identify indications related to rare neurological diseases. The project will leverage Healx’s comprehensive AI-based drug discovery platform, Healnet, and expertise in rare diseases and … Continued

Healx commits $20 million to launch Rare Treatment Accelerator programme; Appoints Dr Bruce Bloom as Chief Collaboration Officer to lead initiative

Cambridge, UK – 21 November 2019 – Healx, the AI-powered and patient-inspired technology company specialising in treatments for rare diseases, today announces that applications are now being accepted for its Rare Treatment Accelerator (RTA). The programme focuses on finding new treatments for rare diseases by partnering with selected rare disease patient groups to leverage the … Continued

Michale Bouskila-Chubb recognised in 50 Movers and Shakers in BioBusiness Report

Michale has been featured in recognition of her contribution to Healx’s business through the negotiation and closing of the company’s first pharma deals, navigating new issues such as data use and IP in drug discovery deals using artificial intelligence (AI). In addition to this, Michale has been instrumental in developing Healx’s business activities through two … Continued

Healx scientists present two new papers at EMNLP 2019 in Hong Kong

Poster #1: Deep Bidirectional Transformers for Relation Extraction without Supervision  NLP Scientist, Yannis Papanikolaou, will be presenting his work on relationship extraction, using a fine-tuning of Google’s BERT language model. Being able to successfully extract relationships despite scarce data is vital to discovering treatments for rare diseases, for which funds – and therefore research – … Continued